Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERTUGLIFLOZIN PIDOLATE vs ESKETAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ERTUGLIFLOZIN PIDOLATE vs ESKETAMINE: Safety Overview

Metric ERTUGLIFLOZIN PIDOLATE ESKETAMINE
Total FAERS Reports 681 15,132
Deaths Reported 4 637
Death Rate 0.6% 4.2%
Hospitalizations 128 2,919
Average Patient Age 57.0 yrs 47.8 yrs
% Female Patients 56.1% 67.0%
FDA Approval Date N/A Mar 5, 2019
Manufacturer Merck Sharp & Dohme LLC Janssen Pharmaceuticals Inc.
Route ORAL NASAL
Marketing Status N/A Prescription